Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease
Benedikt Simbrunner, Ida Falk Villesen, Philipp Königshofer, et al.
Liver International (2022) Vol. 42, Iss. 11, pp. 2501-2512
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Hot and Cold Fibrosis: The Role of Serum Biomarkers to assess the Immune Mechanisms and ECM-Cell Interactions in Human Fibrosis
Andressa de Zawadzki, Diana Julie Leeming, Arun J. Sanyal, et al.
Journal of Hepatology (2025)
Open Access | Times Cited: 1
Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response
Benedikt Simbrunner, Esther Caparrós, Teresa Neuwirth, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 1045-1056
Open Access | Times Cited: 23
Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease
Lorenz Balcar, Julia Krawanja, Bernhard Scheiner, et al.
JHEP Reports (2023) Vol. 5, Iss. 4, pp. 100682-100682
Open Access | Times Cited: 19
Mechanisms of immunity in acutely decompensated cirrhosis and acute‐on‐chronic liver failure
Cornelius Engelmann, Ingrid W. Zhang, J. J. Clariá
Liver International (2023)
Open Access | Times Cited: 16
FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence
Benedikt Simbrunner, Benedikt Hofer, Philipp Schwabl, et al.
Hepatology International (2024) Vol. 18, Iss. 3, pp. 929-942
Open Access | Times Cited: 6
Chinese herbal decoction, Yi-Qi-Jian-Pi formula exerts anti-hepatic fibrosis effects in mouse models of CCl4-induced liver fibrosis
Shiyan Yang, Yajun Cheng, Xiaolong Wang, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26129-e26129
Open Access | Times Cited: 5
Insulin‐like growth factor‐1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver‐related mortality
Lukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Alimentary Pharmacology & Therapeutics (2024)
Open Access | Times Cited: 5
Association between FIB-4 index and lower extremity arterial disease in MASLD patients: a cross-sectional study
Chunxia Zhang, Yuchen Ying, Yuanhui Ru, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome
Benedikt Simbrunner, Ida Falk Villesen, Bernhard Scheiner, et al.
Hepatology International (2023) Vol. 17, Iss. 6, pp. 1532-1544
Open Access | Times Cited: 10
The sclerotic component of metabolic syndrome: Fibroblast activities may be the central common denominator driving organ function loss and death
Alexander Lynge Reese‐Petersen, Signe Holm Nielsen, Jannie Marie Bülow Sand, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 7, pp. 2554-2566
Closed Access | Times Cited: 3
Diabetes impairs the haemodynamic response to non‐selective betablockers in compensated cirrhosis and predisposes to hepatic decompensation
Rafael Paternostro, Mathias Jachs, Lukas Hartl, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 8, pp. 805-813
Open Access | Times Cited: 9
Farnesoid X receptor activation is required for the anti-inflammatory and anti-oxidative stress effects of Alisol B 23-acetate in carbon tetrachloride-induced liver fibrosis in mice
Libei Zhang, Weiling Lin, Yunqing Cai, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110768-110768
Closed Access | Times Cited: 4
Impact of small intestinal bacterial overgrowth on systemic inflammation, circulatory and renal function, and liver fibrosis in patients with cirrhosis and ascites
Olga Alexiou
Annals of Gastroenterology (2024)
Open Access | Times Cited: 1
Hepatotoxicity of oral exposure to 2-methyl-4-nitroaniline: toxicity prediction and in vivo evaluation
Haiwei Liu, Le Cheng, Yili Hu, et al.
Toxicology Letters (2024) Vol. 399, pp. 1-8
Closed Access | Times Cited: 1
High histamine levels are associated with acute‐on‐chronic liver failure and liver‐related death in patients with advanced chronic liver disease
Michael Schwarz, Benedikt Simbrunner, Mathias Jachs, et al.
Liver International (2024) Vol. 44, Iss. 11, pp. 2904-2914
Open Access | Times Cited: 1
Engineered fibrotic liver-targeted truncated transforming growth factor β receptor type II variant for superior anti-liver fibrosis therapy
Manman Ma, Xiaohua Wang, Xiaohui Liu, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 3, pp. 177-191
Closed Access | Times Cited: 4
Discovery and development of palmatine analogues as anti-NASH agents by activating farnesoid X receptor (FXR)
Na Zhang, Tianyun Fan, Liping Zhao, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114886-114886
Closed Access | Times Cited: 7
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study
Thit Mynster Kronborg, Henry Webel, Malene Barfod O’Connell, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
New insights into the role of long non-coding RNAs in osteoporosis
Weifei Zhang, Yuheng Liu, Yuanrui Luo, et al.
European Journal of Pharmacology (2023) Vol. 950, pp. 175753-175753
Closed Access | Times Cited: 2
Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease
Jinming Zhang, Dabao Shang, Qing Xie, et al.
Liver International (2022) Vol. 43, Iss. 3, pp. 735-736
Closed Access | Times Cited: 3
Can Plasma Volume Determination in Cirrhosis Be Replaced by an Algorithm Using Body Weight and Hematocrit?
Martine Prütz Nørskov, Thormod Mønsted, Nina Kimer, et al.
Diagnostics (2024) Vol. 14, Iss. 8, pp. 835-835
Open Access
Extracellular Vesicle-Associated Neutrophil Elastase Activates Hepatic Stellate Cells and Promotes Liver Fibrogenesis via ERK1/2 Pathway
Regina Oshins, Zachary Greenberg, Yunling Tai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Interaction between coagulation and inflammatory system in liver disease: re-focus on hematological markers
Liuyi Lu, Chunling Zhu, Dongyi Zhou, et al.
Biomarkers in Medicine (2024), pp. 1-10
Closed Access
Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosis
Andrea Kornfehl, Anja Tiede, Paul Hemetsberger, et al.
JHEP Reports (2024) Vol. 7, Iss. 4, pp. 101308-101308
Open Access
Page 1 - Next Page

Scroll to top